肌连蛋白预测2型糖尿病的发生
本研究通过横断面和干预研究探讨肌连蛋白与2型糖尿病的关系。新诊断2型糖尿病和糖耐量受损者的循环肌连蛋白水平高于正常人(82.3±47.6 和 68.9±46.6 vs. 45.2±23.5 µg/L,P<0.05或P<0.01),且新诊断2型糖尿病者高于糖耐量受损者。肌连蛋白与腰臀比、体脂百分比、甘油三酯、空腹血糖、糖负荷后2小时血糖、空腹胰岛素、血红蛋白A1c和HOMA-IR正相关,与胰岛素敏感性指数负相关。多因素logistic回归显示肌连蛋白水平与糖耐量受损和2型糖尿病显著相关。急性运动、口服葡萄糖负荷、高胰岛素-正常血糖钳夹或脂质输注诱导的游离脂肪酸升高均未显著改变循环肌连蛋白水平。结论提示肌连蛋白可能是预测糖尿病前期和糖尿病发生的有用标志物。
要点
- 新诊断2型糖尿病和糖耐量受损者循环肌连蛋白高于正常人
- 新诊断2型糖尿病者循环肌连蛋白高于糖耐量受损者
- 急性运动、口服葡萄糖负荷、高胰岛素-正常血糖钳夹或脂质输注均未显著改变循环肌连蛋白
核心结论
- 肌连蛋白可能是预测糖尿病前期和糖尿病发生的有用标志物。
研究设计与样本
- 研究纳入104例新诊断2型糖尿病、109例糖耐量受损和128例健康个体。
- 另设研究进行口服葡萄糖耐量试验、45分钟运动、脂质输注和高胰岛素-正常血糖钳夹,以探讨肌连蛋白与HOMA-IR及2型糖尿病的关联。
- 循环肌连蛋白采用酶联免疫吸附法测定。
主要发现
- 新诊断2型糖尿病和糖耐量受损者的循环肌连蛋白浓度高于正常人(82.3±47.6 和 68.9±46.6 vs. 45.2±23.5 µg/L,P<0.05或P<0.01)。
- 在新诊断2型糖尿病个体中,循环肌连蛋白高于糖耐量受损者。
- 在所有研究人群中,血浆肌连蛋白与腰臀比、体脂百分比、甘油三酯、空腹血糖、糖负荷后2小时血糖、空腹胰岛素、血红蛋白A1c和HOMA-IR正相关,与胰岛素敏感性指数负相关。
- 多因素logistic回归分析显示,循环肌连蛋白水平与糖耐量受损和2型糖尿病显著相关。
- 健康年轻个体进行45分钟运动后循环肌连蛋白水平无变化;口服葡萄糖负荷或高胰岛素-正常血糖钳夹后循环肌连蛋白水平无显著改变;脂质输注诱导的急性游离脂肪酸升高对循环肌连蛋白无影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Myonectin has been identified as a myokine, expressed predominantly in skeletal muscle. However, its clinical implications are largely unknown. OBJECTIVE: The aim of this study is to investigate the relationship between myonectin (C1q tumor necrosis factor-α-related protein isoform 15) and type 2 diabetes mellitus (T2DM) in cross-sectional and interventional studies. DESIGN: In a separate study, oral glucose tolerance tests, a 45-minute bout of exercise, lipid infusions, and euglycemic-hyperinsulinemic clamps (EHCs) were performed to investigate the association of myonectin with homeostasis model assessment of insulin resistance (HOMA-IR) and T2DM. Circulating myonectin was measured by enzyme-linked immunosorbent assay. PATIENTS: One hundred four newly diagnosed T2DM (nT2DM), 109 impaired glucose tolerance (IGT), and 128 healthy individuals were recruited for this study. RESULTS: nT2DM and IGT subjects had higher circulating myonectin concentrations than normal subjects (82.3 ± 47.6 and 68.9 ± 46.6 vs. 45.2 ± 23.5 µg/L, P < 0.05 or P < 0.01). It was also found that in nT2DM individuals, circulating myonectin was higher than in IGT subjects. Plasma myonectin correlated positively with waist/hip ratio, percentage of body fat, triglyceride, fasting blood glucose, 2-hour blood glucose after glucose overload, fasting insulin, hemoglobin A1c, and HOMA-IR and negatively with the insulin sensitivity index in all of the study population. Multivariate logistic regression analysis revealed that circulating myonectin levels were significantly correlated with IGT and T2DM. A 45-minute bout of exercise did not change circulating myonectin levels in healthy, young individuals. Circulating myonectin levels were not significantly altered in response to an oral glucose challenge or EHC. In addition, acute elevated free fatty acid levels induced by lipid infusion had no effects on circulating myonectin. CONCLUSIONS: These data suggest that myonectin may be a useful marker in predicting the development of prediabetes and diabetes.
引用
- Li K, Liao X, Wang K, et al. Myonectin Predicts the Development of Type 2 Diabetes. J Clin Endocrinol Metab. 2018. PMID: 29161407. doi:10.1210/jc.2017-01604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。